Intraparenchymal Neuromonitoring of Cerebral Fat Embolism Syndrome.

brain hypoxia brain tissue oxygenation cerebral fat embolism fat embolism syndrome mean arterial pressure neuromonitoring

Journal

Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 4 6 2021
Statut: epublish

Résumé

We aimed to characterize the cerebrovascular physiology of cerebral fat embolism using invasive multimodal neuromonitoring. ICU, Vancouver General Hospital, Vancouver, BC, Canada. Case report. Patient monitoring software (ICM+, Cambridge, United Kingdom), clinical records, and surgical records. None. Our integrated assessment of the cerebrovascular physiology of fat embolism syndrome provides a physiologic basis to investigate the importance of augmenting mean arterial pressure to optimize cerebral oxygen delivery for the mitigation of long-term neurologic ischemic sequelae of cerebral fat embolism.

Identifiants

DOI: 10.1097/CCE.0000000000000396 PMID: 34079943 PMC: PMC8162500
pubmed: 34079943
doi: 10.1097/CCE.0000000000000396
pmc: PMC8162500
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e0396

Informations de copyright

Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.

Déclaration de conflit d'intérêts

Dr. Hoiland is funded by a Michael Smith Foundation for Health Research Trainee Fellowship, University of British Columbia Bluma Tischler Post-Doctoral Fellowship, and the Darin Daniel Green Memorial Scholarship. Dr. Griesdale is funded through a Health Professional-Investigator Award from the Michael Smith Foundation for Health Research. Dr. Sekhon is funded through the Vancouver Coastal Health Research Institute Clinician Scientist Award and holds a project grant from the Canadian Institutes of Health Research. Dr. Gooderham has disclosed that he does not have any potential conflicts of interest.

Références

Neurocrit Care. 2018 Dec;29(3):358-365
pubmed: 28932982
J Neuroimaging. 2007 Jan;17(1):78-80
pubmed: 17238874
Crit Care Med. 2019 Jul;47(7):960-969
pubmed: 30889022
Eur Neurol. 2017;78(3-4):181-187
pubmed: 28898867
Crit Care Med. 2010 May;38(5):1343-7
pubmed: 20154598
AJNR Am J Neuroradiol. 2014 Jun;35(6):1052-7
pubmed: 23639561

Auteurs

Ryan Leo Hoiland (RL)

Department of Anaesthesiology, Pharmacology and Therapeutics, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
Department of Cellular and Physiological Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Donald E Griesdale (DE)

Department of Anaesthesiology, Pharmacology and Therapeutics, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
Division of Critical Care Medicine, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC, Canada.

Peter Gooderham (P)

Division of Neurosurgery, Department of Surgery, Vancouver General Hospital, University of British Columbia, University of British Columbia, Vancouver, BC, Canada.

Mypinder S Sekhon (MS)

Division of Critical Care Medicine, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

Classifications MeSH